Friday - March 20, 2026

Category Archives: Business

Atopic Dermatitis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | GlaxoSmithKline PLC, Nestle SA, Pfizer Inc., Regeneron Pharma, Abbvie

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 120+ Atopic Dermatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Complement 3 Glomerulopathy Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | NovelMed Therapeutics, Apellis Pharma, Novartis, Amyndas Pharma

The Key Complement 3 Glomerulopathy Companies in the market include – NovelMed Therapeutics, Apellis Pharmaceuticals, Novartis, Amyndas Pharmaceuticals, and others.   DelveInsight’s “Complement 3 Glomerulopathy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Complement 3 … Continue reading →

Diabetic Foot Ulcers Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corp

The Key Diabetic Foot Ulcers Companies in the market include – Amniox (TissueTech), Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corporation, MediWound, Paracrine, INC., NovaLead Pharma, and others.   The Diabetic Foot Ulcers market is expected to … Continue reading →

Advanced Renal Cell Carcinoma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Molecure S.A., Daiichi Sankyo, Janux Therapeutics, NiKang Therapeuti

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of … Continue reading →

Myelofibrosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Galecto Biotech, Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Mye

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myelofibrosis pipeline constitutes 35+ key companies continuously working towards developing 40+ Myelofibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →

Pulmonary Fibrosis Clinical Trial Analysis 2026: 110+ Companies Advancing 140+ Therapies with Breakthrough Clinical Progress, analyses DelveInsight

Pulmonary Fibrosis Pipeline Pulmonary Fibrosis Companies include Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics, Pliant Therapeutics, GlaxoSmithKline, Amgen, Bristol-Myers Squibb, Endeavor Biomedicines, Syndax Pharmaceuticals, Regend Therapeutics, among others. According to DelveInsight’s latest evaluation, the global Pulmonary Fibrosis pipeline includes … Continue reading →

Obsessive Compulsive Disorder Market to Surpass USD 1 Billion by 2034 | 10+ Key Companies Driving Innovation, analyses DelveInsight

Obsessive Compulsive Disorder Market Obsessive Compulsive Disorder (OCD) companies include Biohaven Pharmaceuticals, AbbVie, AstraZeneca, MedtronicNeuro, Hoffmann-La Roche, Ortho-McNeil Pharmaceutical, Forest Laboratories, Eli Lilly and Company, Janssen-Ortho Inc., Pfizer, among others. DelveInsight’s report titled “Obsessive Compulsive Disorder Market Insights, Epidemiology, and … Continue reading →

Alcohol Use Disorder Pipeline Report 2026 Highlights 30+ Companies and 30+ Therapies Shaping Future Treatment Trends, analyses DelveInsight

Alcohol Use Disorder Pipeline Alcohol Use Disorder companies include Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna Pharmaceuticals, Astellas Pharma, Kinnov Therapeutics, MediciNova, Adial Pharmaceuticals, and others According to DelveInsight’s evaluation, the global Alcohol Use Disorder (AUD) … Continue reading →

Hepatocellular Carcinoma Drug Development Landscape Gains Momentum with Over 90 Companies Advancing Innovative Therapies | DelveInsight

Hepatocellular Carcinoma Pipeline Leading Hepatocellular Carcinoma companies involved in this space include Can-Fite BioPharma, Surface Oncology, Novartis Oncology, GlaxoSmithKline, CStone Pharmaceuticals, Chugai Pharmaceutical, and several others. DelveInsight’s latest report, “Hepatocellular Carcinoma Pipeline Insight 2026,” offers an extensive evaluation of the … Continue reading →